Tiziana Life Sciences is trading 10.5% down at $0.91, giving back a portion of its recent gains fueled by insider activity.
- The stock is pulling back after a sharp rally sparked by disclosures that Chairman Gabriele Cerrone increased his stake in the company.
- Today’s move appears to be driven by profit-taking and price normalization rather than any new negative company-specific developments.